As more people turn to AI tools and online algorithms for diet and weight-loss advice, doctors are warning that this growing reliance may be overlooking critical health risks. Doctors stress that AI-generated information should never replace personalised medical...
As a researcher studying how people interact with large language models (LLMs), and as a clinician trained at the master’s level in clinical psychology, I keep seeing the same pattern in fertility and reproductive contexts. People rarely turn to AI only for...
Today, oncology drug development continues to experience the highest attrition rates across therapeutic areas[1]. Despite major advances in molecular profiling and biomarker-driven strategies, a significant proportion of oncology clinical trials still fail, often due...
A New Energy-Centered Model of Metabolic Disease For decades, sugar has been framed as a problem of excess. Too many calories. Too many insulin spikes. Too much sweetness in the modern diet. That framing has shaped public health guidance, food reformulation, and...
Cera, Europe’s largest digital-first home healthcare provider, has announced a global real-world evidence (RWE) partnership with Promptly Health, focused on the over-65s, to accelerate drug development and enable precision medicine. The partnership integrates Cera’s...
Insurance Denials and Revenue Cycle Inefficiencies Are Becoming a Primary Driver of Hospital Financial Strain U.S. hospitals are entering the next fiscal cycle under sustained financial pressure, and insurance denials have emerged as one of the most consequential, yet...
Microsoft is reportedly preparing a major update to its Copilot AI assistant that will let it draw on licensed medical content from Harvard Health Publishing when responding to user queries about healthcare. The development signals a strategic shift toward embedding...
Medical imaging company Hyperfine, listed on the Nasdaq as HYPR, has announced the pricing of an underwritten public offering of 14 million shares of its Class A common stock at $1.25 per share, yielding gross proceeds of approximately $17.5 million before...